From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Kveloce

Company (SME)

kveloce.com/Brussels, Spain
6 profile visits

About

Established in 2011, Kveloce is an international consultancy specializing in supporting Research, Development, and Innovation. We support our clients through the intricacies of securing and managing public funding.   

Our for innovative projects, establishing itself as a trusted and expert partner within the European landscape.  

Kveloce's primary mission is to assist clients in transforming their ideas into innovative projects by identifying and securing the necessary public funding for project execution.   

Recognizing the inherent challenges in both obtaining funding and effectively executing R&I projects, the firm is committed to providing guidance and support at every stage of the process, ensuring project success and impact at the European level.  

A key area of expertise for Kveloce is the comprehensive development of strategic plans for securing public funds for R&I projects. The firm offers services ranging from the initial formulation of the proposal to its final presentation, ensuring that every detail of the project is carefully articulated to meet the requirements and evaluation criteria of the funding entity.

Kveloce also excels in the management and coordination of research projects, providing a holistic approach to ensure the successful implementation of each project. From initial planning to continuous monitoring and final evaluation, the firm works closely with clients to ensure project objectives are achieved within the established timeframe and budget.  

In addition to its core services, Kveloce actively engages in dissemination and knowledge transfer initiatives, promoting the disclosure of project results and facilitating effective knowledge transfer among various stakeholders. These initiatives not only enhance the impact and visibility of projects but also foster collaboration and idea exchange within the scientific and business community.

Areas of Activity

HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancersHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes researchHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicinesHORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Representatives

Trainee

Kveloce

Senior Consultant

Kveloce